Founded in 1990, Paragon Bioservices is a CRO-CMO whose focus is biopharmaceuticals-including the production and purification of monoclonal antibodies, recombinant proteins, viral vectors and vaccines. The company provides research services, process development, and cGMP manufacturing. Paragon's cGMP space includes microbial and mammalian suites, fill-finish and fully-segregated virus and BSL-3 facilities.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/28/14 | $13,000,000 | Series A |
NewSpring Capital | undisclosed |
